# ðŸŽ¯ Tierâ€¯1 Presentation â€“ Executive Overview

> **Speaker Note:** Open with a brief story about why interdisciplinary expertise matters for the Ternary VAE project.

---

## 1ï¸âƒ£ Who is **Carlosâ€¯A.â€¯Brizuela**?

- **Affiliation:** Department of Computer Science, CICESE, Ensenada, Mexico
- **Research Themes:**
  - Antimicrobial peptides & protein design
  - Bioâ€‘informatics algorithms & multiâ€‘objective optimisation
  - Evolutionary computation & ML for drug discovery
- **Credentials:** Ph.D. (Kyoto Institute of Technology, 2001) â€“ >150 peerâ€‘reviewed papers, creator of the _StarPep Toolbox_ and pioneering optimisation frameworks.

> **Speaker Note:** Emphasise his unique blend of computational biology and AI â€“ the exact skill set we need.

---

## 2ï¸âƒ£ Repository at a Glance (Highâ€‘Level)

| Folder                                     | Purpose                                                                                       |
| ------------------------------------------ | --------------------------------------------------------------------------------------------- |
| `src/`                                     | Core VAE implementation, codonâ€‘encoder, custom loss functions                                 |
| `data/`                                    | Curated datasets (geometric vaccine structures, drugâ€‘interaction matrices, peptide libraries) |
| `DOCUMENTATION/01_PROJECT_KNOWLEDGE_BASE/` | Theory, bibliography, and the research library that underpins the science                     |
| `DOCUMENTATION/03_PRESENTATION_TIERS/`     | This folder â€“ the slide decks you are reading now                                             |

> **Speaker Note:** Highlight the cleanâ€‘architecture layout; it makes extensions trivial.

---

## 3ï¸âƒ£ Consolidated Knowledge Base

- **File:** `CARLOS_BRIZUELA_FULL_PROFILE_AND_RESEARCH_REPORT.md`
  - Merges Carlosâ€™ full academic profile, a curated publication list, and a **comprehensive research report** on HIVâ€‘related topics.
- **Validated Findings (HIV focus):**
  1. **Geometric HIV Vaccines** â€“ nanoparticle scaffolds (ferritin, mi3, VLPs) that preserve nativeâ€‘like antigen orientation.
  2. **Lenacapavirâ€¯â†”â€¯Sertraline Interaction** â€“ CYP3A4 inhibition creates a pharmacokinetic penalty.
  3. **FIVâ€¯+â€¯Tenofovir DNA Vaccines** â€“ proofâ€‘ofâ€‘concept for nucleosideâ€‘analogue vaccine strategies.
  4. **Antibioticsâ€¯â†”â€¯Retrovirals** â€“ synergistic immuneâ€‘modulatory effects useful as auxiliary features.
  5. **Codonâ€‘Space Exploration** â€“ a pâ€‘adic metric for codon similarity that informs our codonâ€‘encoder.

> **Speaker Note:** Use a single slide per bullet; keep visuals simple (icons + oneâ€‘line caption).

---

## 4ï¸âƒ£ Why This Drives the **Ternary VAE**

- **Lossâ€‘Function Design:** Directly embed geometricâ€‘design terms and drugâ€‘interaction penalties derived from the literature.
- **Feature Engineering:** Encode antibioticâ€‘retroviral interaction flags and immuneâ€‘biomarker ratios (CD4/CD8) as timeâ€‘varying covariates.
- **Dataset Construction:** Leverage the 30â€‘paper table to build **multiâ€‘task training sets** covering HIV, FIV, and related infectious diseases.
- **Future Extensions:** The same latentâ€‘space framework can be expanded to **panâ€‘infectiousâ€‘disease modelling** (Syphilis, Hepatitis, TB).

> **Speaker Note:** Connect each bullet to a concrete deliverable (e.g., _lossâ€‘function prototype_, _feature matrix_).

---

## 5ï¸âƒ£ Executive Next Steps

1. **Prototype the lossâ€‘function** incorporating the five validated insights.
2. **Populate `data/`** with the curated datasets (geometric structures, interaction matrices, peptide libraries).
3. **Schedule a Tierâ€¯2 technical deepâ€‘dive** with the development team to map implementation details.

> **Speaker Note:** End with a clear callâ€‘toâ€‘action; invite questions.

---

_Prepared for internal review â€“ all sources are documented in the combined profile markdown._
